News | September 24, 2014

ASTRO Presentation Shows How Advanced Image Registration Helps Screen Patients Requiring Adaptive Radiotherapy

September 24, 2014 — Mirada Medical software applied to state-of-the-art adaptive radiotherapy (ART) was the subject of an oral presentation at the annual conference of the American Society for Radiation Oncology (ASTRO) earlier this month in San Francisco.

A critical yet hugely time-consuming step in ART is the monitoring of patients throughout the course of therapy to determine which need to be replanned. This need presents a significant barrier to adoption of ART methods in the clinic. The original research, presented by collaborators from the University Medical Center, Groningen, The Netherlands, examined the possibility of using advanced image registration methods to automate patient monitoring and to flag only those patients that might need further investigation. Such a method can create significant time-savings.

The study included 28 locally advanced head and neck cancer patients treated with intensity-modulated radiation therapy (IMRT). For each patient, the planning target volumes and organs at risk were contoured on the planning computed tomography (CT) scan and propagated to a rescan using deformable image registration (Mirada RTx). Dose distributions of the treatment plan were calculated on both images.

Replanning decisions are usually made by applying constraints to the recalculated dose on the rescan, using the warped structures. However, as a surrogate for recalculation, a dose projection method using a rigid translation applied to the original dose mapped onto the rescan was used. The same set of constraints was then applied to this resulting dose, in order to decide whether a replan was required. The results showed the automated dose projection method correctly removed 90 percent of cases from further evaluation while identifying 100 percent of those that required investigation. This indicates rigid dose projection onto rescan CTs is a fast and automated substitute for dose recalculation since full recalculation and replanning decisions need only be made on those patients flagged by the system.

The study forms part of Mirada’s Registration Assurance program, a comprehensive program for ensuring DIR quality and continuous improvement through rigorous scientific validation of technology, education, comprehensive QC tools and a commitment to ongoing development and support. The registration, contouring and adaptive replanning workflows used in the study are all available in the new releases of Mirada RTx and Mirada Workflow Box.

For more information: www.mirada-medical.com

Related Content

RayCare Oncology Information System Being Shown at ASTRO 2017
News | Radiation Therapy | September 20, 2017
RaySearch will be exhibiting its next-generation oncology information system (OIS) RayCare, among other highlights, at...
Elekta to Highlight MOSAIQ Oncology Analytics at ASTRO Annual Meeting
News | Radiation Therapy | September 19, 2017
September 19, 2017 — Elekta will highlight its Mosaiq Oncology...
Provision Healthcare Joins RayCare Clinical Partners
News | Oncology Information Management Systems (OIMS) | September 11, 2017
Provision, located in Knoxville, Tenn., is the latest to partner with RaySearch Laboratories on the development of its...
German Team Optimizing Therapy Planning for Cancers of the Liver
News | Interventional Radiology | August 29, 2017
Radioembolization is a therapy method used for liver tumors that are uncurable with surgery or chemotherapy. Thorough...
MedStar Georgetown Proton Center Selects RayStation for Treatment Planning
News | Treatment Planning | August 17, 2017
August 17, 2017 — The proton center at MedStar Georgetown University Hospital will utilize RayStation for planning on
DOSIsoft Releases ISOgray Proton Therapy Treatment Planning System
Technology | Treatment Planning | August 15, 2017
DOSIsoft SA announced the official release, with CE marking, of ISOgray Treatment Planning System (TPS) release 4.3 for...
Accuray Receives 510(k) Clearance for iDMS Data Management System
Technology | Oncology Information Management Systems (OIMS) | July 31, 2017
July 31, 2017 — Accuray Inc. announced it has received 510(k) clearance from the U.S.
Eight Proton Therapy Centers Worldwide Adopt RayStation for Treatment Planning
News | Treatment Planning | July 21, 2017
RaySearch Laboratories reported that eight additional proton therapy centers worldwide have recently chosen RayStation...
Catharina Hospital

Catharina Hospital

Sponsored Content | Case Study | Treatment Planning | July 05, 2017
Recently, the oncology department needed to update its radiation therapy treatment planning system. The department...

Photo courtesy of RaySearch

Feature | Treatment Planning | July 05, 2017 | By Jeff Zagoudis
While radiation oncologists have a number of proven techniques at their disposal for treating patients, the reality is...
Overlay Init